DE1484727U - - Google Patents

Info

Publication number
DE1484727U
DE1484727U DENDAT1484727D DE1484727DU DE1484727U DE 1484727 U DE1484727 U DE 1484727U DE NDAT1484727 D DENDAT1484727 D DE NDAT1484727D DE 1484727D U DE1484727D U DE 1484727DU DE 1484727 U DE1484727 U DE 1484727U
Authority
DE
Germany
Prior art keywords
ttt
mmt
tmt
iii
ttttt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1484727D
Other languages
German (de)
English (en)
Publication of DE1484727U publication Critical patent/DE1484727U/de
Active legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1484727D Active DE1484727U (cg-RX-API-DMAC10.html)

Publications (1)

Publication Number Publication Date
DE1484727U true DE1484727U (cg-RX-API-DMAC10.html)

Family

ID=789914

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1484727D Active DE1484727U (cg-RX-API-DMAC10.html)

Country Status (1)

Country Link
DE (1) DE1484727U (cg-RX-API-DMAC10.html)

Similar Documents

Publication Publication Date Title
Montesinos et al. MIRROS: A randomized, placebo-controlled, Phase III trial of cytarabine±idasanutlin in relapsed or refractory acute myeloid leukemia
Oladipo et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue
Rini et al. Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma
Deraco et al. Consensus statement on peritoneal mesothelioma
BRPI0516407A (pt) agonistas de receptor acoplado à proteìna g (gpr116) e uso destes para o tratamento de obesidade e diabetes
Augenstein et al. CeDAR: Carolinas equation for determining associated risks
Scarpa et al. Role of stapled and hand-sewn anastomoses in recurrence of Crohn's disease.
MX2021015328A (es) Agonistas del receptor del peptido-1 similar al glucagon.
US20090191559A1 (en) Her2 diagnostic methods
DE1484727U (cg-RX-API-DMAC10.html)
CA2657324A1 (en) Methods for making cancer prognoses based on subcellular localization of biomarkers
CN102713606A (zh) 用于鉴定、评估、预防和治疗癌症的组合物、试剂盒和方法
Price et al. Current opinion on optimal treatment for colorectal cancer
Li et al. Meta-analysis: E-cadherin immunoexpression as a potential prognosis biomarker related to gastric cancer metastasis in Asian patients.
Eusebi et al. Systematic review with meta‐analysis: risk factors for Barrett's oesophagus in individuals with gastro‐oesophageal reflux symptoms
Gillespie et al. Incidence of wound dehiscence in patients undergoing laparoscopy or laparotomy: a systematic review and meta-analysis
Tejpar et al. Integrating biomarkers in colorectal cancer trials in the West and China
MacConmara et al. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma
Heise et al. Management of bile duct injuries following laparoscopic cholecystectomy
ES2615265T3 (es) Métodos para determinar la probabilidad de supervivencia y para predecir la probabilidad de metástasis en el cáncer
Park et al. Histologic and endoscopic studies before and after gastric bypass surgery.
Veloudis et al. Assessing the clinical utility of Wnt pathway markers in colorectal cancer
Beier et al. Production and characterization of monoclonal antibodies against the antibiotic tilmicosin
Zhao et al. Lymph node yield as a measure of pancreatic cancer surgery quality
Bujanda et al. Colorectal cancer in a second round after a negative faecal immunochemical test